TWA
ARDS

TCI Wealth Advisors’s Aridis Pharmaceuticals Inc. Common Stock ARDS Stock Holding History

TCI Wealth Advisors’s Portfolio ARDS Stock Details ARDS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed – – 2590
2021
Q3 		$0 Buy
+100
New +$462 ﹤0.01% 2639

Other funds holding ARDS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TCI Wealth Advisors's ARDS Position: Q4 2021 in Review

TCI Wealth Advisors sold out of Aridis Pharmaceuticals Inc. Common Stock (ARDS) in Q4 2021, closing a stake of 100 shares.

TCI Wealth Advisors first reported a position in ARDS in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 20 funds tracked by Wall St. Rank hold ARDS as of Q4 2021.

  • TCI Wealth Advisors reported no remaining Aridis Pharmaceuticals Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • TCI Wealth Advisors sold 100 Aridis Pharmaceuticals Inc. Common Stock shares in Q4 2021.
  • TCI Wealth Advisors first reported a position in Aridis Pharmaceuticals Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • TCI Wealth Advisors's Aridis Pharmaceuticals Inc. Common Stock position peaked at $0 in Q3 2021.
  • 20 funds tracked by Wall St. Rank held Aridis Pharmaceuticals Inc. Common Stock as of Q4 2021.

Based on TCI Wealth Advisors's 13F filing for Q4 2021, filed 24 Jan 2022.